A mechanistic exploration of the metabolome of African mango seeds and its potential to alleviate cognitive impairment induced by high-fat/high-carbohydrate diets …

YR Hassan, RA El-Shiekh, HM El Hefnawy… - Journal of …, 2024 - Elsevier
Abstract Ethnopharmacological relevance Irvingia gabonensis (Aubry-Lecomte ex O'Rorke)
Baill., also known as “African mango” or “bush mango”, belonging to family Irvingiaceae, has …

[PDF][PDF] Biomarkers of diabetes: role in the pathogenesis of atrial fibrillation.

S Rafaqat, IR Vujačić, S Gluscevic… - European Review for …, 2024 - europeanreview.org
The prevalence of both atrial fibrillation (AF) and diabetes is increasing day by day and
commonly co-exist with a longer duration of diabetes and poor control, putting the individual …

Orlistat for the treatment of antipsychotic-induced weight gain: an eight-week multicenter, randomized, placebo-controlled, double-blind trial

P Xie, T Shao, Y Long, W Xie, Y Liu, Y Yang… - Lipids in Health and …, 2024 - Springer
Background Weight gain and metabolic disorders are commonly induced by antipsychotics.
Orlistat is a lipase inhibitor used for weight control. The effect of orlistat on weight gain and …

[HTML][HTML] Real-World Evidence of a Hospital-Linked Digital Health App for the Control of Hypertension and Diabetes Mellitus in South Korea: Nationwide Multicenter …

S Park, HG Woo, S Kim, S Kim, H Lim… - JMIR Formative …, 2023 - formative.jmir.org
Background: Digital health care apps have been widely used for managing chronic
conditions such as diabetes mellitus and hypertension, providing promising prospects for …

[PDF][PDF] In silico elucidation of plausible anti-obesity activity by Withaferin-A compound targeting alpha-amylase.

A Alafnan, AK Chettupalli, A Unnisa… - European Review for …, 2023 - europeanreview.org
OBJECTIVE: The study aimed to evaluate the Withaferin-A against the drug target α-
amylase, revealing its plausible mode of action and molecular-level interactions essential for …

Indian Academy of Pediatrics Revised Guidelines on Evaluation, Prevention and Management of Childhood Obesity

V Khadilkar, N Shah, R Harish, A Ayyavoo, A Bang… - Indian Pediatrics, 2023 - Springer
Justification The last guidelines for pediatric obesity were released in 2004 by Indian
Academy of Pediatrics (IAP). Since then, there has been an alarming increase in prevalence …

[PDF][PDF] Atorvastatin versus tetrahydrolipstatin in male patients with dyslipidemia: A systematic review and meta-analysis

NA Hasan, VP Kalanjati, KE Purwantari… - Journal of Pharmacy & …, 2024 - academia.edu
Context: Atorvastatin is typically used in the treatment of dyslipidemia. However, the interest
in using anti-obesity medications such as orlistat has grown rapidly as obesity is one of the …

Potential anti-obesity/inflammatory flavonoid-derived biomolecules against Obesity to prevent WAT differentiation by targeting a DNA-binding protein inhibitor, ID-1

JS Alanazi, A Unnisa, MS Alanazi… - Cellular and Molecular …, 2023 - cellmolbiol.org
A concoction of unhealthy eating, inactivity, and the adverse effects of specific drugs brings
on obesity. The primary cause of Obesity is the storage of too much energy and triglycerides …

A Clinical Review of Adult Obesity and Weight Management in the United States

M Helf - 2024 - repository.rit.edu
The standard of care for obesity has been lifestyle modifications, dietary changes and the
use of some anti-obesity medications, however, given the increased rate of growth of obesity …